The rapid development of vaccines against COVID-19 should be a positive, life-saving development. Happening at a speed many in the medical field would have previously thought impossible, these vaccines provide a glimmer of hope that an end to this once-in-a-century pandemic is possible. But instead of national governments and pharmaceutical companies cooperating to vaccinate the world’s population as quickly as possible, other priorities are informing the distribution of vaccines.